Mangafodipir

DRUG4 trials

Sponsors

Egetis Therapeutics, Assistance Publique - Hôpitaux de Paris, National Institute of Neurological Disorders and Stroke (NINDS)

Conditions

CancerChemotherapyColon CancerEpilepsyMyocardial InfarctionNeurotoxic Disorders

Phase 1

Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy

RecruitingNCT02531880

National Institute of Neurological Disorders and Stroke (NINDS)Epilepsy

Start: 2024-11-19End: 2030-07-01Target: 40Updated: 2026-09-16

Phase 2

Mangafodipir as an Adjunct to FOLFOX6 Chemotherapy in Colon Cancer Stage Dukes' C

CompletedNCT00671996

Egetis TherapeuticsChemotherapy, Colon Cancer

Start: 2008-06-30End: 2010-04-30Updated: 2010-05-04

Protective Effect of Mangafodipir Against Oxaliplatin Neurotoxicity

CompletedNCT00727922

Assistance Publique - Hôpitaux de ParisCancer, Neurotoxic Disorders

Start: 2008-06-30End: 2011-04-30Updated: 2025-11-20

Mangafodipir as an Adjunct to Percutaneous Coronary Intervention

CompletedNCT00966563

Egetis TherapeuticsMyocardial Infarction

Start: 2009-12-31End: 2013-07-31Updated: 2013-07-16

Related Papers

Treatment of oxaliplatin-induced peripheral neuropathy by intravenous mangafodipir

Journal of Clinical Investigation2013-12-1982 citations